(198 days)
The PhotoGenica sV laser is indicated for the treatment of recurrent respiratory papillomatosis of the glottis.
The PhotoGenica sV is a pulse-dye laser, having the organic dye as the lasting medium. It is pulsed dye laser with a wavelength of 585nm. Laser activation is by footswitch. Overall weight of the laser is 285lbs. and the size is 44"x19"x24" (HxWxD). Electrical requirement is 110 VAC or 220 VAC, 20A, 50-60 Hz, single phase.
The provided 510(k) summary for the Cynosure PhotoGenica sV Laser indicates that it is a medical laser system intended for the treatment of recurrent respiratory papillomatosis of the glottis.
This document describes a medical device, which is different from an AI/ML powered device. Medical devices, especially those like lasers, go through a different approval process than AI/ML algorithms. The provided text does not contain any information about acceptance criteria or a study proving device performance as typically expected for an AI/ML powered device.
Therefore, I cannot provide the requested information regarding acceptance criteria, study details, sample sizes, expert qualifications, or ground truth methods because such information is not typically included in a 510(k) summary for a non-AI/ML medical device like a laser system.
The "Comparison" section states: "The PhotoGenica sV laser has an equivalent indication for uses, the same principle of operation, the same wavelength and pulse energy range as the predicate devices." This suggests that the device was approved based on its substantial equivalence to a legally marketed predicate device (PhotoGenica V), rather than a de novo clinical study establishing performance against specific acceptance criteria.
In summary, none of the requested information regarding acceptance criteria and study details for an AI/ML powered device is available in the provided text.
{0}------------------------------------------------
NOV 2 0 2002
.
--
510(k) Summary
:
:
:
:
:
| 510(k) Summary | ||
|---|---|---|
| Submitter: | Cynosure, Inc. 10 Elizabeth Drive Chelmsford, MA 01824 | K021444 |
| Contact: | George Cho | |
| Date Summary Prepared: | November 20, 2002 | |
| Device Trade Name: | PhotoGenica sV | |
| Common Name: | Medical Laser System | |
| Classification Name: | Instrument, surgical, powered, laser 79-GEX 21 CFR 878.48 | |
| Equivalent Device: | PhotoGenica V | |
| Device Description: | The PhotoGenica sV is a pulse-dye laser, having the organic dye as the lasting medium. It is pulsed dye laser with a wavelength of 585nm. | |
| Laser activation is by footswitch. Overall weight of the laser is 285lbs. and the size is 44"x19"x24" (HxWxD). | ||
| Electrical requirement is 110 VAC or 220 VAC, 20A, 50-60 Hz, single phase. | ||
| Intended Use: | The PhotoGenica sV is indicated for treatment of recurrent respiratory papillomatosis of the glottis. | |
| Comparison: | The PhotoGenica sV laser has an equivalent indication for uses, the same principle of operation, the same wavelength and pulse energy range as the predicate devices. | |
| Conclusion: | The PhotoGenica sV laser is another safe and effective device for soft tissue application. | |
| Additional Information: | None. |
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or a stylized human figure with outstretched arms.
Public Health Service
NOV 2 0 2002
Food and Drug Administratio 00 Corporate Boulevard Rockville MD 20850
Cynosure, Inc. George Cho Senior Vice President 10 Elizabeth Drive-Chelmsford, Massachusetts 01824
Re: K021444
Trade/Device Name: Cynosure PhotoGenica sV Laser Regulation Number: 878.4810 Regulation Name: Powered surgical laser instrument Regulatory Class: Class II Product Code: GEX Dated: August 21, 2002 Received: August 22, 2002
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
{2}------------------------------------------------
Page 2 - Mr. George Cho
quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
-Miriam C. Provost
Celia M. Witten, Ph.D., MD Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
510(k) Number (if known): K021444
Device Name: Cynosure PhotoGenica sV Laser
Indications For Use:
The PhotoGenica sV laser is indicated for the treatment of recurrent respiratory papillomatosis of the glottis.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Miriam C. Provost
(Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number KC2/444
Prescription Use
OR
Over-The-Counter Use_
(Optional Formal 1-2-96)
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.